Ozempic vs Wegovy: What Is the Difference in 2026?
Ozempic and Wegovy both contain semaglutide, the same active ingredient, but they are different FDA-approved products with different indications, doses, and insurance coverage. Ozempic (up to 2 mg weekly) is approved for type 2 diabetes and cardiovascular risk reduction (the LEADER trial, NEJM 2016). Wegovy (2.4 mg weekly) is approved for chronic weight management (the STEP 1 trial, NEJM 2021). Understanding the difference matters for insurance coverage, prescribing eligibility, and cost.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Ozempic and Wegovy both contain semaglutide, the same active ingredient, but they are approved for different indications and come in different doses. Ozempic (semaglutide 0.5 mg, 1 mg, 2 mg) is FDA-approved for type 2 diabetes management and cardiovascular risk reduction in adults with established cardiovascular disease. Wegovy (semaglutide 2.4 mg) is FDA-approved specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
The practical difference is dose and indication. Wegovy's 2.4 mg maintenance dose is higher than Ozempic's maximum 2 mg dose, which is why the weight-loss efficacy data are slightly stronger for Wegovy. Ozempic is not FDA-approved for weight loss — prescribing it for that purpose is off-label. Insurance coverage differs significantly: Ozempic is covered by most commercial plans for diabetes; Wegovy coverage is inconsistent and often requires prior authorisation. Telehealth providers who prescribe semaglutide for weight loss typically use Wegovy or compounded semaglutide, not Ozempic.
SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Found
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Side-by-Side Comparison
| Attribute | SkinnyRx | Found |
|---|---|---|
| Program Fee | Included in monthly plan | $129/mo CORE plan ($99/mo on 6 months); GLP-1 medication separate |
| Medication From | From $99 – $199/mo | From $129 – $349/mo |
| Editor Score | 4.3 / 5 | 4.2 / 5 |
| Primary Category | GLP-1 Weight Loss | GLP-1 Weight Loss |
| FDA Brand-Name Access | Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo | Wegovy, Zepbound, Ozempic, Rybelsus, Saxenda, Trulicity, Victoza |
| Compounded Options | 4 compounds | 2 compounds |
| Adjacent Categories | GLP-1 Weight Loss | GLP-1 Weight Loss |
What the Studies Actually Show
Both products contain semaglutide. Efficacy data cited is from the STEP programme (NEJM 2021) for Wegovy and the SUSTAIN-6 programme (NEJM 2016) for Ozempic. Insurance coverage and prescribing eligibility vary by plan and clinical profile.
| Endpoint | SkinnyRx | Found |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA-approved indication | Type 2 diabetes; cardiovascular risk reduction in T2D with established CVD | Chronic weight management (obesity or overweight with comorbidity) |
| Maximum approved dose | 2 mg weekly (subcutaneous injection) | 2.4 mg weekly (subcutaneous injection) |
| Mean weight loss in pivotal trial1,2 | ~5-7% (SUSTAIN programme, T2D population) | -14.9% (STEP 1, 68 weeks, non-diabetic obesity population) |
| Cardiovascular outcomes | LEADER trial: 14% reduction in MACE in T2D with established CVD | SELECT trial: 20% reduction in MACE in non-diabetic obesity with established CVD |
| Typical retail price (without insurance) | ~$900-$1,200/month | ~$1,349-$1,700/month |
Who Should Choose Ozempic vs Wegovy
Choose Ozempic if…
- You have type 2 diabetes: Ozempic is approved for it, so insurance is far more likely to cover it.
- Your plan covers Ozempic for diabetes but excludes weight-loss drugs.
Choose Wegovy if…
- You don't have type 2 diabetes and your goal is weight management: Wegovy is the on-label choice.
- You want doses up to 2.4 mg (or 7.2 mg with Wegovy HD) and the cardiovascular-risk indication.
- You're paying cash: Wegovy has published self-pay prices ($349 a month for the pen, $149 to $299 for the pill).
Monthly Cost Compared
| Ozempic | Wegovy | |
|---|---|---|
| Approved use | Type 2 diabetes (and related risk reduction) | Chronic weight management and cardiovascular risk reduction |
| Self-pay price we found | From $199/month (pen), as listed by Hims and WeightWatchers Clinic | $349/month pen (NovoCare); $199 for the first two fills for new patients; pill $149 to $299 |
| With commercial coverage | Typically covered for type 2 diabetes | As little as $25/month with the savings offer, if your plan covers it |
Prices checked October 21, 2026. Ozempic used for weight loss alone is off-label; your prescriber decides which product fits.
The Verdict
If your primary goal is weight management and you do not have type 2 diabetes, Wegovy is the on-label choice. If you have type 2 diabetes and weight loss is a secondary goal, Ozempic may be covered by insurance under the diabetes indication. Both are prescribed by the same telehealth platforms; the prescribing clinician will determine which is appropriate based on your clinical profile.
Frequently Asked Questions
Is Ozempic the same as Wegovy?
Both contain semaglutide, but at different doses and with different FDA indications. Ozempic is approved for type 2 diabetes at doses up to 2 mg weekly. Wegovy is approved for chronic weight management at 2.4 mg weekly. They are manufactured by Novo Nordisk and use the same injection device design.
Can I use Ozempic for weight loss?
Ozempic can be prescribed off-label for weight loss, particularly in patients with type 2 diabetes or prediabetes. For patients without diabetes whose primary goal is weight management, Wegovy (the weight-management-indicated formulation at 2.4 mg) is the on-label choice and may have different insurance coverage.
Which is cheaper. Ozempic or Wegovy?
Ozempic has a lower retail list price (~$900-$1,200/month vs $1,349-$1,700/month for Wegovy). However, insurance coverage depends on the indication: Ozempic may be covered under a diabetes benefit, while Wegovy may require a separate obesity-management benefit. Out-of-pocket costs vary significantly by plan.
Which telehealth providers prescribe both Ozempic and Wegovy?
SkinnyRx, Found Health, FeelGood, and Synergy Rx all carry both Ozempic and Wegovy on formulary and can prescribe either based on your clinical profile and insurance coverage.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.